Abstract
We describe a general protocol for using comparative NMR metabolomics data to infer in vivo efficacy, specificity and toxicity of chemical leads within a drug discovery program. The methodology is demonstrated using Aspergillus nidulans to monitor the activity of urate oxidase and orotidine-5′- phosphate decarboxylase and the impact of 8-azaxanthine, an inhibitor of urate oxidase. 8-azaxanthine is shown to inhibit A. nidulans hyphal growth by in vivo inactivation of urate oxidase.
Original language | English (US) |
---|---|
Pages (from-to) | 1916-1923 |
Number of pages | 8 |
Journal | Journal of proteome research |
Volume | 5 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2006 |
Keywords
- Aspergillus nidulans
- Drug discovery
- Metabolomics
- NMR
- Principle component analysis
- Purine degradation pathway
- Pyrimidine biosynthetic pathway
ASJC Scopus subject areas
- Biochemistry
- Chemistry(all)